SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001213900-17-011833
Filing Date
2017-11-13
Accepted
2017-11-13 15:55:29
Documents
51
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO QUARTERLY REPORT f10q0916a1_immudyneinc.htm 10-Q/A 584879
2 CERTIFICATION f10q0916a1ex31-1_immudyne.htm EX-31.1 17415
3 CERTIFICATION f10q0916a1ex32-1_immudyne.htm EX-32.1 4463
  Complete submission text file 0001213900-17-011833.txt   3918291

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE immd-20160930.xml EX-101.INS 901933
5 XBRL SCHEMA FILE immd-20160930.xsd EX-101.SCH 30004
6 XBRL CALCULATION FILE immd-20160930_cal.xml EX-101.CAL 24847
7 XBRL DEFINITION FILE immd-20160930_def.xml EX-101.DEF 142736
8 XBRL LABEL FILE immd-20160930_lab.xml EX-101.LAB 303359
9 XBRL PRESENTATION FILE immd-20160930_pre.xml EX-101.PRE 227793
Mailing Address 50 SPRING MEADOW ROAD MT. KISCO NY 10549
Business Address 50 SPRING MEADOW ROAD MT. KISCO NY 10549 (914) 244-1777
Immudyne, Inc. (Filer) CIK: 0000948320 (see all company filings)

IRS No.: 760238453 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 000-55857 | Film No.: 171195717
SIC: 2833 Medicinal Chemicals & Botanical Products